Bausch + Lomb BLCO Surgical — Total revenues
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bausch + Lomb in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Bausch + Lomb’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bausch + Lomb's surgical — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Bausch + Lomb's surgical — total revenues?
- Bausch + Lomb (BLCO) reported surgical — total revenues of $228M in Q1 2026.
- How has Bausch + Lomb's surgical — total revenues changed year-over-year?
- Bausch + Lomb's surgical — total revenues increased by 6.5% year-over-year, from $214M to $228M.
- What is the long-term trend for Bausch + Lomb's surgical — total revenues?
- Over 4 years (2021 to 2025), Bausch + Lomb's surgical — total revenues has grown at a 5.6% compound annual growth rate (CAGR), from $718M to $894M.
- What does surgical — total revenues mean?
- The total gross income generated from the sale of surgical products, including intraocular lenses and specialized surgical equipment. This is the primary measure of the surgical segment's market demand and top-line performance. Growth in this metric indicates successful product adoption and market penetration within the ophthalmic surgical space.